LMD in Dextrose (Hospira, Inc.)
Welcome to the PulseAid listing for the LMD in Dextrose drug offered from Hospira, Inc.. This Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hospira, Inc. |
NON-PROPRIETARY NAME: | DEXTRAN 40 |
SUBSTANCE NAME: | DEXTRAN 40 |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 1992-10-30 |
END MARKETING DATE: | 0000-00-00 |
LMD in Dextrose HUMAN PRESCRIPTION DRUG Details:
Item Description | LMD in Dextrose from Hospira, Inc. |
LABELER NAME: | Hospira, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(g/100mL) |
START MARKETING DATE: | 1992-10-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0409-7418_d73450a5-90e4-4fd4-aa0e-44d4dcbd6c17 |
PRODUCT NDC: | 0409-7418 |
APPLICATION NUMBER: | BA720563 |
Other DEXTRAN 40 Pharmaceutical Manufacturers / Labelers: